US$ 24.51
bpc 157 pub med Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of and Related Therapeutics What Science ACTUALLY Says About
Description
[8] They found no acute toxicity at doses up to 10 mg/kg

the validated Primary Care Patient Measure of Safety

GHK-Cu is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use

JMS Journal of Medical Society 2007;21(3):13842

The standard anchor is 2 mg GHK-Cu daily

Counteracted were the severe lesions and hemorrhage in the brain, lungs, liver, kidney, and gastrointestinal tract
